• News
  • BioTech

Illumina gains on report of higher Roche bid

Illumina Inc. (Nasdaq: ILMN) gained in New York trading after Swiss newspaper L'Agefi said Roche Holding AG may have agreed to buy the U.S. maker of DNA sequencing equipment at a price 48 percent higher than its original unsuccessful bid.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments
Subscribe Today!